Roivant Sciences garners interest for multi-billion bowel drug â Bloomberg | WTVB
(Reuters) – Roivant Sciences Ltd is attracting interest from large pharmaceutical companies for its inflammatory bowel disease drug, Bloomberg
See Original Article
UK plans to reverse ban on EU-era securities rule, Bloomberg reports – Reuters
British Finance Minister Jeremy Hunt is planning to repeal a piece of European Union-era legislation that required financial businesses to
See Original Article
Leave a Reply